- 'One of the single biggest barriers to growth': UK lawmakers press banks over crypto access ahead of new FCA regime
- Bitcoin miner Riot lands $9B Anthropic lease: Assessing impact on BTC as revenue expands
- The French media organization Alliance de la presse d'information générale has filed a complaint with the French antitrust regulator regarding Google's (GOOG.US) artificial intelligence business.
- ‘Bitcoin Is Anti-Gold,’ Urges Top Stockbroker Peter Schiff. Should You Sell Bitcoin and Strategy Stock?
- Autolus Q2 net loss narrows 18.38% to $39.11 million; net product revenue more than doubles 119% to $45.7 million
- SunHydrogen signs technology collaboration agreement with Sparc Hydrogen
- Phio Pharma wins U.S. patent allowance for BRD4-targeting INTASYL compound PH-894
- APPLIED MATERIALS INC : WILLIAM BLAIR ASSUMES COVERAGE WITH MARKET PERFORM RATING
- BioXcel amends Oaktree-led credit agreement, cuts minimum liquidity covenant to $3 million
- Gain Therapeutics Q2 FY26 net loss narrows to $0.11 a share; R&D expenses fall 24.64% to $2.1 million
- Tango Therapeutics Q2 net loss widens to $55.3 million; G&A expenses climb 99% to $22.6 million
- Alaska Silver plans C$ 7.62 million PIPE at C$ 0.55 per unit
- Xtant Medical Q2 FY26 turns to net loss of $9.41 million; revenue drops 34.96% to $23.03 million
- Hub Group delays Q2 10-Q filing after 2025 annual report setback
- TENAX THERAPEUTICS INC <TENX.O>: WILLIAM BLAIR CUTS TO MARKET PERFORM RATING
- Enviri Q2 FY26 GAAP diluted loss widens to $10.70 per share; revenue falls 41% to $187 million
- Pirate Gold appoints ex-Gold Fields chief geologist Rael Lipson as strategic advisor
- Ceragon Q2 FY26 net loss widens to $2.1 million; revenue rises 14.2% to $93.9 million
- Hemab Q2 FY26 net loss widens to $24.15 million; R&D expenses rise to $20.34 million
- XTI Aerospace delays Q2 2026 financial results release
- Perma-Fix reschedules Q2 2026 business update conference call
- Bitcoin sell pressure ‘closer to exhaustion’ after $4B USDT market-cap drop: CryptoQuant
- Vestis FY26 Q3 swings to net income of $11.05 million; revenue falls 1.8% to $661.7 million vs FY25 Q3
- Beyond Meat announces 1-for-30 reverse stock split
- Aldebaran Resources shareholders approved Centauri spinout plan at annual meeting
- Barnwell FY26 Q3 net loss narrows to $440,000; revenue rises to $3.38 million
- Green Thumb subsidiaries RSLGH, VMS amend RYTHM warrants, notes to lift beneficial ownership limits
- DPC Holdings Q2 FY26 net loss widens to $131 million; revenue climbs 34% to $269 million
- ECARX Q2 FY26 net loss narrows to US$12 million; revenue rises 45% to US$225.2 million
- VinFast unit VinSpace signs SpaceX launch contract for 2027 satellite rideshare mission
- Middleby FY26 Q2 net earnings drop to 54.81 million; net sales rise 9.9% to 875.55 million
- Elysee Q2 FY26 turns to net loss of CAD 665,865
- Anavex faces PVG activist slate seeking board seats at Sept. 24 shareholder meeting
- X-energy unit TRISO-X extends ORNL advanced nuclear fuel R&D pact
- 908 Devices Q2 FY26 adjusted EBITDA loss narrows 50% to $1.9 million; revenue rises 23% to $16.1 million
- Terrestrial Energy Q2 FY26 net loss narrows to $9.4 million; cash falls 5.37% vs Q1 to $283.4 million
- Popular CEO Javier D. Ferrer sells 35,000 shares for $6.14 million
- Baker Hughes wins multi-year contract with Kuwait Oil for Ahmadi Innovation Valley project
- Kardigan Q2 FY26 net loss widens to $116.24 million; R&D expenses rise to $56.37 million
- GSP Resource completes 1,801-meter Phase 1 drill program at Alwin and Mer properties in British Columbia
- Bioxytran reports functional gains in first CIDP patient treated with PLICID galectin antagonist
- Profits are impressive, AI monetization is just beginning, HSBC declares 'the global stock market banquet is far from over'
- US Treasury yields and the US dollar rise in tandem, oil prices climb, strengthening expectations of a rate hike in September; CPI report becomes a key variable
- BRIEF-Xtant Medical Q2 Revenue USD 23 Million
- BRIEF-Neo Performance Materials Q2 Adjusted EPS USD 0.55
- C4 Therapeutics Q2 FY26 net loss narrows to $23.6 million; revenue rises to $6.6 million
- Legend Biotech 2Q Rev $387.5M >LEGN
- Group 1 Automotive adds ex-Ulta CEO Dave Kimbell to board, audit committee
- LINCOLN EDUCATIONAL SERVICES CORP <LINC.O>: ROSENBLATT SECURITIES CUTS TARGET PRICE TO $50 FROM $60
- Senmiao proposes USD 5 million partnership with Energence Utah on 100 MW data center campus buildout
- Goldman Sachs trims Scout24 voting rights stake to 5.48% from 6.24%
- XRP $5 call sparks debate as analysts, investors question bullish 12 month target
- MoneyMax 1H FY26 profit attributable to owners jumps 77.3% to S$52.55 million; revenue rises 34.1% to S$325.7 million
- MoneyMax unit buys Aquilia Holdings for MYR 100
- How Nvidia's Huang and Meta's Zuckerberg Are -2-
- Janus International Group Cuts 2026 View To Rev $925M-$945M >JBI
- BRIEF-Janus International Q2 Adjusted EPS USD 0.17 Vs. IBES Estimate USD 0.15
- Janus International Q2 FY26 net income falls 48.3% to $10.7 million; revenue rises 2.4% to $233.5 million
- NIQ GLOBAL INTELLIGENCE <NIQ.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $15 FROM $14
- VSE CORPORATION <VSEC.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $290 FROM $280
- HIMS & HERS <HIMS.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $26 FROM $25
- Janus International Group 2Q Adj EPS 17c >JBI
- Janus International Group 2Q Rev $233.5M >JBI
- Janus International Group 2Q EPS 8c >JBI
- Cineplex Q2 2026 revenue rises 9.8% as attendance increases, company says
- Marfrig buys back 10.63 million shares for R$ 160.72 million
- US Treasuries hold steady ahead of CPI; oil prices approach $90, intensifying tension; 30-year yield hits near 20-year high
- Cardinal Infrastructure Q2 FY26 net income rises 18% to $11.1 million; revenue more than doubles to $226.9 million
- Cardinal Infra Group 2Q Net $11.1M >CDNL
- Cardinal Infra Group Raises 2026 View To Rev $880M-$900M >CDNL
- Cardinal Infra Group Backlog as of June 30, 2026 Was $866 M >CDNL
- Cardinal Infrastructure Group Inc. Reports Second Quarter 2026 Results And Updates 2026 Outlook, Announces Acquisition Of Allied Paving >CDNL
- Jiutian Chemical says arbitration claim is withdrawn, tribunal orders claimant to pay RMB 70,000 costs
- Basler supervisory board member Dr. Holger Singpiel buys shares for EUR 4,630
- Cardinal Health Sees FY Global Medical Products and Distribution Segment Rev Grwoth of 2% to 4% >CAH
- Cardinal Health Sees FY Pharmaceutical and Specialty Solutions Segment Rev Growth of 3% to 5% >CAH
- Cardinal Health 4Q Pharmaceutical and Specialty Solutions Segment Rev Increased 6% to $58.8B >CAH
- Cardinal Health 4Q Global Medical Products and Distribution Segment Rev Decreased 2% to $3.1B >CAH
- ABCELLERA BIOLOGICS INC. : BMO RAISES TARGET PRICE TO $15 FROM $7
- Cardinal Health Sees FY Adj EPS $12.40-Adj EPS $12.60 >CAH
- BRIEF-Cardinal Health Q4 Adjusted EPS USD 2.91 Vs. IBES Estimate USD 2.42
- HIMS & HERS HEALTH, INC. <HIMS.N>: NEEDHAM RAISES TARGET PRICE TO $42 FROM $35
- Yimutian announces annual shareholder meeting
- IHS Holding announces availability of Q2 2026 earnings release
- Jacobs wins CUWCD engineering role on USD 750 million Utah Strawberry High Line water pipeline project
- Blue Moon Metals acquires 33 US tungsten, antimony projects for US$5 million and 2,800,000 shares
- Twenty One Capital targets Berkshire-style buildout of operating businesses around Bitcoin balance sheet
- Major Canadian Economic Indicators Expected This Week
- Cardinal Health 4Q Adj EPS $2.91 >CAH
- Cardinal Health 4Q EPS $1.70 >CAH
- TARGET CORP <TGT.N>: BMO RAISES TARGET PRICE TO $150 FROM $130
- Lithium Argentina Q2 2026 profit falls as company cites US$ 38 million deferred tax charge at Cauchari-Olaroz JV
- H&R REIT releases presentation for Aug. 11, 2026 joint conference call on GO REIT deal
- NUTRIEN LTD <NTR.N>: BARCLAYS CUTS TARGET PRICE TO $78 FROM $81
- IHS Holding amends USD 200 million term loan, resets margin schedule
- Tritech 1Q FY27 net loss widens 27.1% to S$ 1.01 million; revenue falls 4.3% to S$ 4.56 million
- Cardinal Health declares quarterly dividend of $0.52 per share
- Nutriplant returns to profit with 6M FY26 net income of R$ 538,000; net revenue falls 34.1% to R$ 74.14 million
- Vireo Q2 FY26 adjusted EBITDA climbs 212% to US $41.5 million; GAAP revenue rises 335.1% to US $209.3 million
- P&P Immobilienverwaltung, closely associated with Athos board member Manfred Pammer, buys 350 Athos shares (ISIN AT0000616701) at 43.00 per share
